Law360
DOJ Kickback Concerns Extend Beyond Federal Funds
April 13, 2022
The federal government has expressed growing interest in pursuing enforcement actions focused on alleged kickbacks in the health care industry that it cannot reach with its tried-and-true lever, the Anti-Kickback Statute.
Specifically, where alleged kickback arrangements do not implicate federal funds, the U.S. Department of Justice increasingly is turning to the Travel Act and the Eliminating Kickbacks in Recovery Act, or EKRA.
Contacts
Capabilities
Suggested News & Insights
Exclusive Fireside Chat: A Conversation With FDA's Chief CounselTuesday, January 12, 2027Recharge & Recaffeinate With Sidley @ JPMMonday, January 11, 2027 – Tuesday, January 12, 2027CMS Announces Plans to Expand Voluntary Cell and Gene Therapy Access Model Beyond Sickle Cell DiseaseNovember 12, 2026DOJ Announces $13 Million Settlement with Defense and Aerospace Contractors, Alleging Failures to Meet Cybersecurity RequirementsNovember 11, 2026DOJ and EEOC Announce $29.5 Million Two-Part Settlement with Lockheed Martin, the Fourth FCA Resolution Targeting Alleged Employment DiscriminationNovember 5, 2026Sidley Represents Laza Medical in Its US$160 Million Series B Financing RoundNovember 4, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
